Search results for "call"

showing 10 items of 2320 documents

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and ov…

2016

Orally administered drugs are subject to a number of barriers impacting bioavailability (Foral), causing challenges during drug and formulation development. Physiologically-based pharmacokinetic (PBPK) modelling can help during drug and formulation development by providing quantitative predictions through a systems approach. The performance of three available PBPK software packages (GI-Sim, Simcyp®, and GastroPlus™) were evaluated by comparing simulated and observed pharmacokinetic (PK) parameters.Since the availability of input parameters was heterogeneous and highly variable, caution is required when interpreting the results of this exercise. Additionally, this prospective simulation exer…

Physiologically based pharmacokinetic modellingChemistryBiopharmaceuticsDrug Evaluation PreclinicalArea under the curveAdministration OralPharmaceutical ScienceModels Biological030226 pharmacology & pharmacyBiopharmaceuticsBioavailabilityClinical studyToxicology03 medical and health sciences0302 clinical medicineIntestinal AbsorptionPharmaceutical PreparationsPharmacokineticsCompounding030220 oncology & carcinogenesisStatisticsHumansComputer SimulationImmediate releaseForecastingEuropean Journal of Pharmaceutical Sciences
researchProduct

Oral biopharmaceutics tools – Time for a new initiative – An introduction to the IMI project OrBiTo

2013

OrBiTo is a new European project within the IMI programme in the area of oral biopharmaceutics tools that includes world leading scientists from nine European universities, one regulatory agency, one non-profit research organization, four SMEs together with scientists from twelve pharmaceutical companies. The OrBiTo project will address key gaps in our knowledge of gastrointestinal (GI) drug absorption and deliver a framework for rational application of predictive biopharmaceutics tools for oral drug delivery. This will be achieved through novel prospective investigations to define new methodologies as well as refinement of existing tools. Extensive validation of novel and existing biopharm…

Physiologically based pharmacokinetic modellingComputer scienceProcess (engineering)Chemistry Pharmaceuticalmedia_common.quotation_subjectAdministration OralPharmaceutical SciencePharmacologyModels BiologicalPermeabilityQuality by DesignBiopharmaceuticsAnimalsHumansComputer SimulationPharmacokineticsQuality (business)Product (category theory)Program Developmentmedia_commonDosage FormsActive ingredientbusiness.industryBiopharmaceuticsGastrointestinal TractEngineering managementIntestinal AbsorptionPharmaceutical PreparationsSolubilityNew product developmentbusinessEuropean Journal of Pharmaceutical Sciences
researchProduct

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysin…

2016

Three Physiologically Based Pharmacokinetic software packages (GI-Sim, Simcyp® Simulator, and GastroPlus™) were evaluated as part of the Innovative Medicine Initiative Oral Biopharmaceutics Tools project (OrBiTo) during a blinded “bottom-up” anticipation of human pharmacokinetics. After data analysis of the predicted vs. measured pharmacokinetics parameters, it was found that oral bioavailability (Foral) was underpredicted for compounds with low permeability, suggesting improper estimates of intestinal surface area, colonic absorption and/or lack of intestinal transporter information. Foral was also underpredicted for acidic compounds, suggesting overestimation of impact of ionisation on pe…

Physiologically based pharmacokinetic modellingIn silicoDrug Evaluation PreclinicalAdministration OralPharmaceutical Science02 engineering and technologyPharmacologyModels Biological030226 pharmacology & pharmacyBiopharmaceutics03 medical and health sciences0302 clinical medicineLow permeabilityHumansComputer SimulationChemistryBiopharmaceutics021001 nanoscience & nanotechnologyBioavailabilityIntestinal AbsorptionPharmaceutical PreparationsColonic absorptionSystem parametersIntestinal surfaceBiochemical engineering0210 nano-technologyForecasting
researchProduct

Predicting Pharmacokinetics of Multisource Acyclovir Oral Products Through Physiologically Based Biopharmaceutics Modeling.

2021

Abstract Highly variable disposition after oral ingestion of acyclovir has been reported, although little is known regarding the underlying mechanisms. Different studies using the same reference product (Zovirax ®) showed that Cmax and AUC were respectively 44 and 35% lower in Saudi Arabians than Europeans, consistent with higher frequencies of reduced-activity polymorphs of the organic cation transporter (OCT1) in Europeans. In this study, the contribution of physiology (i.e., OCT1 activity) to the oral disposition of acyclovir immediate release (IR) tablets was hypothesized to be greater than dissolution. The potential role of OCT1 was studied in a validated physiologically-based biopharm…

Physiologically based pharmacokinetic modellingIn vitro dissolutionChemistryBiopharmaceuticsCmaxPharmaceutical ScienceAcyclovirBioequivalencePharmacologyBiopharmaceuticsOral ingestionPharmacokineticsSolubilityTherapeutic EquivalencyImmediate releaseTabletsJournal of pharmaceutical sciences
researchProduct

Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making

2021

Atorvastatin (ATS) is the gold-standard treatment worldwide for the management of hypercholesterolemia and prevention of cardiovascular diseases associated with dyslipidemia. Physiologically based pharmacokinetic (PBPK) models have been positioned as a valuable tool for the characterization of complex pharmacokinetic (PK) processes and its extrapolation in special sub-groups of the population, leading to regulatory recognition. Several PBPK models of ATS have been published in the recent years, addressing different aspects of the PK properties of ATS. Therefore, the aims of this review are (i) to summarize the physicochemical and pharmacokinetic characteristics involved in the time-course o…

Physiologically based pharmacokinetic modellingModel predictionAtorvastatinPopulationPharmaceutical ScienceReviewTarget populationComputational biologyP-glycoprotein030226 pharmacology & pharmacy03 medical and health sciencesPharmacy and materia medica0302 clinical medicinePharmacokineticsmedicineopen acid formeducationeducation.field_of_studybusiness.industrysolubilityatorvastatinactive metabolitesRS1-441lactonizationDose optimizationMetabolic enzymes030220 oncology & carcinogenesisbusinessmedicine.drugPharmaceutics
researchProduct

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

2020

MBQ-167 is a dual inhibitor of the Rho GTPases Rac and Cdc42 that has shown promising results as an anti-cancer therapeutic at the preclinical stage. This drug has been tested in vitro and in vivo in metastatic breast cancer mouse models. The aim of this study is to develop a physiologically based pharmacokinetic/pharmacodynamic (PBPK-PD) model of MBQ-167 to predict tumor growth inhibition following intraperitoneal (IP) administration in mice bearing Triple Negative and HER2+ mammary tumors. PBPK and Simeoni tumor growth inhibition (TGI) models were developed using the Simcyp V19 Animal Simulator. Our developed PBPK framework adequately describes the time course of MBQ-167 in each of the mo…

Physiologically based pharmacokinetic modellinglcsh:RS1-441Pharmaceutical ScienceSpleenPharmacologyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinebreast cancerPharmacokineticsIn vivomedicinePotency030304 developmental biology0303 health sciencesMammary tumorbusiness.industryMBQ-167medicine.diseaseMetastatic breast cancermedicine.anatomical_structure030220 oncology & carcinogenesisPharmacodynamicsRac inhibitorphysiologically based pharmacokinetic modelingbusinessPharmaceutics
researchProduct

Arabidopsis copper transport protein COPT2 participates in the crosstalk between iron deficiency responses and low phosphate signaling

2013

[EN] Copper and iron are essential micronutrients for most living organisms because they participate as cofactors in biological processes, including respiration, photosynthesis, and oxidative stress protection. In many eukaryotic organisms, including yeast (Saccharomyces cerevisiae) and mammals, copper and iron homeostases are highly interconnected; yet, such interdependence is not well established in higher plants. Here, we propose that COPT2, a high-affinity copper transport protein, functions under copper and iron deficiencies in Arabidopsis (Arabidopsis thaliana). COPT2 is a plasma membrane protein that functions in copper acquisition and distribution. Characterization of the COPT2 expr…

PhysiologyArabidopsisPlant SciencePlant RootsMembranes Transport and BioenergeticsGene Expression Regulation PlantArabidopsisThalianaHomeostasisArabidopsis thalianaSLC31 ProteinsGene-expressionCation Transport ProteinsChlorosisbiologyRevealsIron DeficienciesMetal homeostasisPlantsPlants Genetically ModifiedUp-RegulationTransport proteinPhenotypeBiochemistrySignal TransductionIronRecombinant Fusion ProteinsSaccharomyces cerevisiaechemistry.chemical_elementSaccharomyces cerevisiaeModels BiologicalPhosphatesEthyleneGeneticsmedicineBIOQUIMICA Y BIOLOGIA MOLECULARFamilyIron deficiency (plant disorder)Arabidopsis ProteinsBiological TransportRoot elongationSequence Analysis DNAbiology.organism_classificationmedicine.diseaseCopperPlant LeavesAcquisitionchemistrySeedlingsStarvationMutationCopper deficiencyCopper
researchProduct

Morphogenesis and Cardenolide Formation in Digitalis obscura Cultures

1991

Summary Cardenolide formation was investigated in hypocotyl cultures of Digitalis obscura L. established on MS medium with growth regulators selected to promote either callus formation, caulogenesis, embryogenesis or rhizogenesis. Examination of the cardenolide composition of leaves from mature plants was also performed. Several compounds of series A and C were identified by HPLC in in vitro and in vivo grown tissues, no marked differences being found between their cardenolide patterns. RIA determinations showed that shoot- or embryo-forming calli accumulated significantly higher amounts of digoxigenin derivatives than undifferentiated or rhizogenic cultures. In any case, field plants prese…

PhysiologyCallus formationfungiDigitalis obscurafood and beveragesPlant ScienceBiologybiology.organism_classificationHypocotylTissue culturechemistry.chemical_compoundMurashige and Skoog mediumchemistryBiochemistryShootBotanyCardenolideDigoxigeninAgronomy and Crop ScienceJournal of Plant Physiology
researchProduct

Paratransgenic manipulation of a tsetse microRNA alters the physiological homeostasis of the fly’s midgut environment

2021

Tsetse flies are vectors of parasitic African trypanosomes, the etiological agents of human and animal African trypanosomoses. Current disease control methods include fly-repelling pesticides, fly trapping, and chemotherapeutic treatment of infected people and animals. Inhibiting tsetse’s ability to transmit trypanosomes by strengthening the fly’s natural barriers can serve as an alternative approach to reduce disease. The peritrophic matrix (PM) is a chitinous and proteinaceous barrier that lines the insect midgut and serves as a protective barrier that inhibits infection with pathogens. African trypanosomes must cross tsetse’s PM in order to establish an infection in the fly, and PM struc…

PhysiologyGenes InsectBiochemistryAnimals Genetically ModifiedMedical ConditionsGene expressionMedicine and Health SciencesHomeostasisPeritrophic matrixBiology (General)Protozoans0303 health sciencesbiologyGene OntologiesSodalis glossinidiusEukaryotaCardiaGenomicsBody FluidsCell biologyIntestinesNucleic acidsBloodDigestionAnatomyResearch ArticleSymbiotic bacteriaTrypanosomaTsetse FliesQH301-705.5ImmunologyParatransgenesisMicrobiology03 medical and health sciencesVirologyParasitic DiseasesGeneticsAnimalsNon-coding RNAMolecular Biology030304 developmental biologyNatural antisense transcripts030306 microbiologyfungiOrganismsBiology and Life SciencesComputational BiologyTsetse flyMidgutRC581-607Genome Analysisbiology.organism_classificationParasitic ProtozoansGastrointestinal MicrobiomeInsect VectorsGene regulationGastrointestinal TractMicroRNAsTrypanosomiasis AfricanTrypanosomaRNAParasitologyGene expressionImmunologic diseases. AllergyPhysiological ProcessesDigestive SystemPLOS Pathogens
researchProduct

The Arabidopsis COPT6 Transport Protein Functions in Copper Distribution Under Copper-Deficient Conditions

2013

Copper (Cu), an essential redox active cofactor, participates in fundamental biological processes, but it becomes highly cytotoxic when present in excess. Therefore, living organisms have established suitable mechanisms to balance cellular and systemic Cu levels. An important strategy to maintain Cu homeostasis consists of regulating uptake and mobilization via the conserved family of CTR/COPT Cu transport proteins. In the model plant Arabidopsis thaliana, COPT1 protein mediates root Cu acquisition, whereas COPT5 protein functions in Cu mobilization from intracellular storage organelles. The function of these transporters becomes critical when environmental Cu bioavailability diminishes. Ho…

PhysiologyMolecular Sequence DataSaccharomyces cerevisiaeMutantArabidopsisSaccharomyces cerevisiaePlant SciencePlant RootsCofactorCell membraneGene Expression Regulation PlantArabidopsisOrganellemedicineHomeostasisAmino Acid SequenceSLC31 ProteinsbiologyArabidopsis ProteinsMembrane transport proteinCell MembraneGenetic Complementation TestMembrane Transport ProteinsBiological TransportCell BiologyGeneral MedicinePlants Genetically Modifiedbiology.organism_classificationUp-RegulationTransport proteinCell biologyPlant LeavesMutagenesis Insertionalmedicine.anatomical_structureBiochemistrySeedsbiology.proteinPlant Vascular BundleSequence AlignmentCopperPlant ShootsPlant and Cell Physiology
researchProduct